Clinical Trials in Dallas

Showing 5061-5080 of 17,468 trials

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

NCT01906385

This is a multi-center, sequential cohort, open-label, volume and dose escalation study of the safety, tolerability, and distribution of 186RNL given by convection enhanced delivery to patients with recurrent or progressive malignant glioma after standard surgical, radiation, and/or chemotherapy treatment. The study uses a modified Fibonacci dose escalation, followed by an expansion at the maximum tolerated dose (MTD) to determine efficacy. The starting absorbed dose is 1mCi in a volume of 0.660mL.

Glioma

Plus Therapeutics55 participantsStarted Jun 2015

Manhasset, New York, United States • Dallas, Texas, United States • San Antonio, Texas, United States

COMPLETEDNA31 miles

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

NCT03241459

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.

Peripheral Arterial DiseasePeripheral Vascular DiseaseArtery Disease, Peripheral+1 more

SurModics, Inc.446 participantsStarted Oct 2017

Birmingham, Alabama, United States • Foley, Alabama, United States • Gilbert, Arizona, United States +60 more locations

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

Find Trials by Condition in Dallas

BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Oral Administration of STC-15 in Subjects With Advanced Malignancies

Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Study to Investigate Hepatic Impairment on PK, Safety, Tolerability of Camizestrant in Post-Menopausal Female Subjects

PArtial REbreathing for Migraine With Aura 1

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

MIP Versus PCNL for Kidney Stone Disease

Outcomes of a Skill-Based Program for Eating Disorders

Efficacy of Emotionally Focused Therapy Among Spanish Speaking Couples

Urine CXCL10 Monitoring Trial in Kidney Transplant

Kids FACE FEARS Comparative Effectiveness Research